Early markers of myocardial injury: cTnI is enough

Clinica Chimica Acta

Volumn 400, Issue 1-2, 2009, Pages 82-85

  Ilva, Tuomo ^a   Lund, Juha ^a   Porela, Pekka ^a   Mustonen, Harri ^b   Voipio Pulkki, Liisa Maria ^b   Eriksson, Susann ^a   Pettersson, Kim ^a   Tanner, Pirjo ^b   Pulkki, Kari ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Diagnosis; H FABP; Myocardial infarction; Prognosis; Troponin

Indexed keywords

BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; TROPONIN I;

ACUTE CORONARY SYNDROME; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; HEART MUSCLE INJURY; HEART REINFARCTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SYMPTOM;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; MYOCARDIUM; PATIENT ADMISSION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TROPONIN I;

EID: 57949109476     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.10.005     Document Type: Article

References (27)

1. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21 (2000) 1502-1513
2. Thygesen K., Alpert J.S., and White H.D. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 28 (2007) 2525-2538
3. Heidenreich P.A., Alloggiamento T., Melsop K., McDonald K.M., Go A.S., and Hlatky M.A. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 38 (2001) 478-485
4. Lindahl B. Detection of myocardial damage-are the troponins the ultimate solution?. Scand Cardiovasc J 35 (2001) 229-232
5. Morrow D.A., Cannon C.P., Jesse R.L., et al. National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 115 (2007) e356-375
6. Jaffe A.S., Babuin L., and Apple F.S. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 48 (2006) 1-11
7. Ilva T., Eriksson S., Lund J., et al. Improved early risk stratification and diagnosis of myocardial infarction, using a novel troponin I assay concept. Eur J Clin Invest 35 (2005) 112-116
8. Venge P., Lagerqvist B., Diderholm E., Lindahl B., and Wallentin L. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II Substudy). Am J Cardiol 89 (2002) 1035-1041
9. James S., Flodin M., Johnston N., Lindahl B., and Venge P. The antibody configurations of cardiac troponin I assays may determine their clinical performance. Clin Chem 52 (2006) 832-837
10. Lam Q., Black M., Youdell O., Spilsbury H., and Schneider H.G. Performance evaluation and subsequent clinical experience with the Abbott Automated Architect STAT Troponin-I assay. Clin Chem 52 (2006) 298-300
11. Azzazy H.M., Pelsers M.M., and Christenson R.H. Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications. Clin Chem 52 (2006) 19-29
12. O Donoghue M., de Lemos J.A., Morrow D.A., et al. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation 114 (2006) 550-557
13. Kilcullen N., Viswanathan K., Das R., et al. EMMACE-2 Investigators. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. J Am Coll Cardiol 50 (2007) 2061-2067
14. Bagwe S., Sachdeva R., and Mehta J.L. High-risk acute coronary syndrome patient and cardiac biomarkers in the emergency department: where do we stand?. Eur Heart J 28 (2007) 1044-1045
15. Kumpula E.K., Eriksson S., Laaksonen P., and Pettersson K. Point-of-care immunoassay for determination of heart-type fatty acid-binding protein using a dry reagent concept. Clin Chem Lab Med 39 (2001) S182
16. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more receiver operating characteristic curves; a nonparametric approach. Biometrics 44 (1988) 837-845
17. Van Nieuwenhoven F.A., Kleine A.H., Wodzig W.H., et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 92 (1995) 2848-2854
18. Sorichter S., Mair J., Koller A., Pelsers M.M., Puschendorf B., and Glatz J.F. Early assessment of exercise induced skeletal muscle injury using plasma fatty acid binding protein. Br J Sports Med 32 (1998) 121-124
19. Tanaka T., Hirota Y., Sohmiya K., Nishimura S., and Kawamura K. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem 24 (1991) 195-201
20. Kleine A.H., Glatz J.F., Van Nieuwenhoven F.A., and Van der Vusse G.J. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 116 (1992) 155-162
21. Tambara K., Fujita M., Miyamoto S., Doi K., Nishimura K., and Komeda M. Pericardial fluid level of heart-type cytoplasmic fatty acid-binding protein (H-FABP) is an indicator of severe myocardial ischemia. Int J Cardiol 93 (2004) 281-284
22. Ishii J., Ozaki Y., Lu J., et al. Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome. Clin Chem 51 (2005) 1397-1404
23. Seino Y., Tomita Y., Takano T., and Ohbayashi K. Tokyo Rapid-Test Office Cardiologists (Tokyo-ROC) Study. Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction: comparison between heart-type fatty acid-binding protein and troponin T tests. Circ J 68 (2004) 144-148
24. Ecollan P., Collet J.P., Boon G., et al. Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay. Int J Cardiol 119 (2007) 349-354
25. Chan C.P., Sanderson J.E., Glatz J.F., Cheng W.S., Hempel A., and Renneberg R. A superior early myocardial infarction marker. Human heart-type fatty acid-binding protein. Z Kardiol 93 (2004) 388-397
26. McCann C.J., Glover B.M., Menown I.B., et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J (Aug 5, 2008) [Epub ahead of print]
27. Hjortshøj S., Dethlefsen C., Kristensen S.R., and Ravkilde J. Improved assay of cardiac troponin I is more sensitive than other assays of necrosis markers. Scand J Clin Lab Invest 68 (2008) 130-133